| scholarly article | Q13442814 |
| P2093 | author name string | Samy Hadjadj | |
| Stéphanie Ragot | |||
| Pierre-Jean Saulnier | |||
| Aurelie Miot | |||
| Florence Torremocha | |||
| Philippe Sosner | |||
| Richard Marechaud | |||
| Wala Hammi | |||
| Xavier Piguel | |||
| P2860 | cites work | Heart rate as a risk factor for developing chronic kidney disease: longitudinal analysis of a screened cohort. | Q51830152 |
| The separate and joint effects of prolonged QT interval and heart rate on mortality | Q59150390 | ||
| QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up | Q79345669 | ||
| Heart rate as a predictor of development of sustained hypertension in subjects screened for stage 1 hypertension: the HARVEST Study | Q80130256 | ||
| Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease | Q81537671 | ||
| Resting heart rate in patients with stable coronary artery disease and diabetes: a report from the euro heart survey on diabetes and the heart | Q85175905 | ||
| Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies | Q24608301 | ||
| The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes | Q28188182 | ||
| Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study | Q28291971 | ||
| A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Q29614889 | ||
| Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy | Q29615215 | ||
| Diabetes mellitus, fasting glucose, and risk of cause-specific death | Q33945937 | ||
| Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus | Q34222683 | ||
| Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial | Q34817084 | ||
| Elevated heart rate: a major risk factor for cardiovascular disease | Q36035810 | ||
| Mechanical stretch induces vascular permeability factor in human mesangial cells: mechanisms of signal transduction | Q36637348 | ||
| Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Dia | Q36842087 | ||
| Resting heart rate in cardiovascular disease | Q36919145 | ||
| Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms | Q37027950 | ||
| Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents | Q37068649 | ||
| The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study | Q37125667 | ||
| Elevated heart rate and cardiovascular outcomes in patients with coronary artery disease: clinical evidence and pathophysiological mechanisms | Q37691724 | ||
| Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis | Q37719080 | ||
| Vascular pathophysiology in response to increased heart rate | Q37815268 | ||
| Heart rate predicts outcomes in an implantable cardioverter-defibrillator population | Q38377756 | ||
| Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study | Q40347311 | ||
| Bedside risk stratification after acute myocardial infarction: prospective evaluation of the use of heart rate and left ventricular function | Q40423025 | ||
| Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment | Q43458408 | ||
| Heart rate and cardiovascular mortality: the Framingham Study | Q43463488 | ||
| Effects on heart rate variability of metoprolol supplementary to ongoing ACE-inhibitor treatment in Type I diabetic patients with abnormal albuminuria | Q44075863 | ||
| Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study | Q44502984 | ||
| Heart-rate profile during exercise as a predictor of sudden death | Q44886530 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | risk analysis | Q11679892 |
| P304 | page(s) | 2069-2075 | |
| P577 | publication date | 2012-07-18 | |
| P1433 | published in | Diabetes Care | Q5270111 |
| P1476 | title | Prognostic value of resting heart rate on cardiovascular and renal outcomes in type 2 diabetic patients: a competing risk analysis in a prospective cohort | |
| P478 | volume | 35 |
| Q58803910 | Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes |
| Q36448435 | Resting Heart Rate Does Not Predict Cardiovascular and Renal Outcomes in Type 2 Diabetic Patients |
| Q45058890 | Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies. |
Search more.